Dr Tamura has recently retired as representative director, executive vice president and chief science officer of Astellas Pharma.
Dr Tamura has received a PhD degree from the University of Tokyo, Graduate School of Pharmaceutical Sciences.
Thomas Neff, president and CEO of FibroGen, said: “We are honored that Dr Tamura has agreed to join our board of directors. We look forward to working with this experienced pharmaceutical executive who has extensive knowledge of R&D, regulatory and manufacturing matters as we advance all aspects of our business.”